Category: Disease Prevention & Management

In a pivotal gathering held this June in Chicago, the American Medical Association (AMA) House of Delegates convened to deliberate and establish essential policy positions that will shape the landscape of American healthcare for providers and patients alike. Among the thousands of medical professionals in attendance, the Endocrine Society was represented by a dedicated delegation…

The ENDO annual meeting, organized by the Endocrine Society, stands as the preeminent global gathering for the endocrinology community, serving as a vital nexus where clinical practice, cutting-edge research, and professional mentorship converge. As the community reflects on recent gatherings and looks forward to future installments, including ENDO 2026 in Chicago and the anticipated return…

Understanding the Metabolic Burden of Endogenous Cushing’s Syndrome Endogenous Cushing’s syndrome is a rare but severe endocrine disorder characterized by the chronic overproduction of cortisol, often resulting from a pituitary tumor (Cushing’s disease) or an adrenal tumor. Cortisol, frequently referred to as the "stress hormone," plays a vital role in regulating metabolism, immune response, and…

Acromegaly is a rare and chronic endocrine condition caused by the overproduction of growth hormone (GH), almost exclusively due to a benign tumor, or adenoma, on the pituitary gland. This excessive secretion triggers the liver to produce elevated levels of insulin-like growth factor 1 (IGF-I). Together, these hormones drive systemic changes throughout the body, including…

The Clinical Crisis: A Case of Metabolic Collapse The patient, a 76-year-old man recently diagnosed with multiple myeloma, was undergoing a standard treatment regimen intended to stabilize his skeletal integrity. Multiple myeloma is a hematologic malignancy known for its aggressive impact on the skeletal system, where malignant plasma cells stimulate osteoclasts—the cells responsible for breaking…

A comprehensive multicenter study recently published in The Journal of Clinical Endocrinology & Metabolism has uncovered a significant gender-based disparity in the effectiveness of growth-promoting therapies for children with classical congenital adrenal hyperplasia (CAH). The research, which analyzed long-term outcomes for patients with the most common form of the condition, suggests that while hormonal interventions…

The study, titled “The Role of Obstructive Sleep Apnea and CPAP Therapy in the Functional Hypogonadism of Male Patients with Severe Obesity,” was conducted by a multidisciplinary team of researchers who sought to disentangle the complex relationship between respiratory distress during sleep and endocrine health. By analyzing a cohort of 204 male inpatients, the investigators…

The landscape of obesity research shifted significantly during the ENDO 2026 conference in Chicago, Illinois, as Rok Herman, MD, was honored with the 2026 C. Wayne Bardin, MD, International Travel Award. Dr. Herman, an internal medicine resident at the University Medical Centre Ljubljana in Slovenia, received the prestigious accolade for his pioneering abstract regarding the…

The global pharmaceutical landscape underwent a significant shift on July 6 as Vertex Pharmaceuticals, Inc. and Crinetics Pharmaceuticals, Inc. announced a definitive merger agreement that positions Vertex as a major player in the specialized field of endocrinology. Under the terms of the agreement, Vertex will acquire all outstanding shares of Crinetics for $85.00 per share…

The publication of a rare clinical case in the March edition of JCEM Case Reports has sparked renewed interest in the pharmacological management of primary hyperparathyroidism (PHPT), a condition typically requiring surgical intervention for definitive resolution. Sara Ramadan, MD, a resident at the Boston Medical Center-Brighton and a member of the Boston University Chobanian &…